Evidence map›Paper›PMID 39450180›Full record

ArticleFrontiers in immunology2024

Exploring the naturally acquired response to Pvs47 gametocyte antigen.

Gisele Tatiane Soares da Veiga, Rafael Amaral Donassolo, Sofia Forcellini, Julia Weber Ferraboli, Mario Antonio Kujbida Junior, Líndice Mitie Nisimura, Letícia Werzel Bassai, Rafael Luis Kessler, Mariana Serpeloni, Najara Carneiro Bittencourt and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Naturally acquired antibodies toFrontiers in immunology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Gisele Tatiane Soares da VeigaLaboratório de Pesquisa em Apicomplexa, Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, PR, Brazil.
Rafael Amaral DonassoloLaboratório de Pesquisa em Apicomplexa, Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, PR, Brazil.
Sofia ForcelliniLaboratório de Pesquisa em Apicomplexa, Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, PR, Brazil.
Julia Weber FerraboliLaboratório de Pesquisa em Apicomplexa, Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, PR, Brazil.
Mario Antonio Kujbida JuniorLaboratório de Pesquisa em Apicomplexa, Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, PR, Brazil.
Líndice Mitie NisimuraLaboratório de Pesquisa em Apicomplexa, Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, PR, Brazil.
Letícia Werzel BassaiInstituto de Biologia Molecular do Paraná (IBMP), Curitiba, Brazil.
Rafael Luis KesslerInstituto de Biologia Molecular do Paraná (IBMP), Curitiba, Brazil.
Mariana SerpeloniInstituto de Biologia Molecular do Paraná (IBMP), Curitiba, Brazil.
Najara Carneiro BittencourtLaboratório de Doenças Tropicais Prof. Dr. Luiz Jacintho da Silva, Departamento de Genética, Evolução, Microbiologia e Imunologia, Universidade de Campinas - UNICAMP, Campinas, Brazil.
Yanka Evellyn Alves R SalazarBiologia Molecular e Imunologia da Malária, Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil.
Luiz Felipe Ferreira GuimarãesBiologia Molecular e Imunologia da Malária, Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil.
Jaime LouzadaLaboratório de Parasitologia e Monitoramento de Artrópodes Vetores na Amazônia, Centro de Ciências da Saúde, Universidade Federal de Roraima (UFRR), Boa Vista, Brazil.
Dayanne Kamylla Alves da Silva BarrosFundação de Medicina Tropical Doutor Heitor Vieira Dourado (FMT-HVD), Manaus, Brazil.
Stefanie Costa Pinto LopesFundação de Medicina Tropical Doutor Heitor Vieira Dourado (FMT-HVD), Manaus, Brazil.
Luzia Helena CarvalhoBiologia Molecular e Imunologia da Malária, Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil.
Tais Nóbrega de SousaBiologia Molecular e Imunologia da Malária, Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil.
Flora Satiko KanoBiologia Molecular e Imunologia da Malária, Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil.
Fabio Trindade Maranhão CostaLaboratório de Doenças Tropicais Prof. Dr. Luiz Jacintho da Silva, Departamento de Genética, Evolução, Microbiologia e Imunologia, Universidade de Campinas - UNICAMP, Campinas, Brazil.
Pryscilla Fanini WowkGrupo de Imunologia Celular e Molecular, Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, PR, Brazil.
Letusa AlbrechtLaboratório de Pesquisa em Apicomplexa, Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, PR, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria represents a challenging global public health task, with

Indexed as

Antibodies, ProtozoanAntigens, ProtozoanImmunoglobulin GImmunoglobulin MMalaria, VivaxPlasmodium vivaxAdolescentAdultBrazilFemaleHumansMalaria VaccinesMaleMiddle AgedYoung AdultAntibodies, ProtozoanAntigens, ProtozoanImmunoglobulin GImmunoglobulin MMalaria VaccinesantigenicitygametocytemalariaPlasmodium vivaxPvs47transmission blocking vaccine

Identifiers

PMID39450180
PMCPMC11499161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.